Topic: investors funding round details
-
Stem Cell Therapies for Pets: Coming Soon!
Stem cell therapies for pets are advancing, with Gallant's $18 million funding boost potentially leading to the first FDA-approved ready-to-use treatment for animals, revolutionizing chronic condition management. Gallant's initial focus is Feline Chronic Gingivostomatitis (FCGS), with promising r...
Read More »